Viewing Study NCT02580994


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-25 @ 9:49 PM
Study NCT ID: NCT02580994
Status: COMPLETED
Last Update Posted: 2023-12-11
First Post: 2015-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in Untreated Extensive SCLC
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module